Continuing cyclin-dependent kinase 4/6 inhibition in metastatic breast cancer patients previously treated with another cyclin-dependant kinase 4/6 inhibitor: a protocol for systematic review and meta-analysisAlicia de Luna Aguilar, José Á. García-Sáenz, Carmen Toledano Rojas et al.|Research Square|2022Cited by 3
Continuing cyclin dependent kinase 4/6 inhibition with abemaciclib in metastatic breast cancer patients previously treated with palbociclib or ribociclib: a protocol for systematic review and meta-analysisAlicia de Luna Aguilar, José Á. García-Sáenz, Alfonso Lopez de Sa Lorenzo et al.|Research Square|2022Cited by 0
Continuing cyclin-dependent kinase 4/6 inhibition in metastatic breast cancer patients previously treated with another cyclin-dependant kinase 4/6 inhibitor: a protocol for systematic review and meta-analysisAlicia de Luna Aguilar, José Á. García-Sáenz, Fernando Moreno Antón et al.|Research Square|2022Cited by 0